Advanz Pharma Corp Stock

Advanz Pharma Corp Debt 2024

Advanz Pharma Corp Debt

0 USD

Ticker

CXRXF

ISIN

JE00BJVH6L55

WKN

A2PYQF

In 2024, Advanz Pharma Corp's total debt was 0 USD, a 0% change from the 0 USD total debt recorded in the previous year.

Advanz Pharma Corp Aktienanalyse

What does Advanz Pharma Corp do?

Advanz Pharma Corp Ltd is an international pharmaceutical company that focuses on the development, manufacturing, and marketing of generics and specialty pharmaceuticals. The company is headquartered in London and operates numerous subsidiaries worldwide. Answer: Advanz Pharma Corp Ltd is an international pharmaceutical company that specializes in developing, manufacturing, and marketing generics and specialty pharmaceuticals. It was founded in 2015 through the merger of two well-known generic drug manufacturers: Canadian company Concordia International Corp and Irish company Warner Chilcott plc. Advanz Pharma is listed on the Bombay Stock Exchange and the National Stock Exchange of India since 2017. Answer: Advanz Pharma has its own business model that emphasizes the marketing and development of generics and specialty pharmaceuticals. The company focuses on providing cost-effective medical solutions by producing generic versions of products whose patent has expired or is about to expire. These medications are typically more affordable than their original counterparts. However, the company also manufactures specialty pharmaceuticals that specialize in rare diseases, oncology, and hormonal disorders. Answer: Advanz Pharma is divided into several divisions to produce various types of medications, such as: - Cardiology - Oncology - Gastroenterology - Neurology - Antibiotics - Diabetic care - Endocrinology and reproduction Answer: Advanz Pharma manufactures a wide range of generics and specialty pharmaceuticals. Some of the products include: - Metformin, an antidiabetic medication - Carbidopa/levodopa, a medication for treating Parkinson's disease - Ezetimibe, for lowering cholesterol levels - Doxorubicin, a cancer medication - Hydroxyzine, an antiallergic medication - Methotrexate, a cancer and rheumatoid arthritis medication Answer: In conclusion, Advanz Pharma Corp Ltd is an international generics and specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of cost-effective medications. The company has a broad product portfolio that includes both generics and specialized medications. It aims to provide cost-effective solutions to improve access to essential healthcare. Advanz Pharma Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Advanz Pharma Corp's Debt Structure

Advanz Pharma Corp's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Advanz Pharma Corp's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Advanz Pharma Corp’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Advanz Pharma Corp’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Advanz Pharma Corp stock

What is the debt of Advanz Pharma Corp this year?

Advanz Pharma Corp has a debt level of 0 USD this year.

What was the debt of Advanz Pharma Corp compared to the previous year?

The debt of Advanz Pharma Corp has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Advanz Pharma Corp?

High debt can pose a risk for investors of Advanz Pharma Corp, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Advanz Pharma Corp?

Low debt means that Advanz Pharma Corp has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Advanz Pharma Corp affect the company?

An increase in debt of Advanz Pharma Corp can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Advanz Pharma Corp affect the company?

A reduction in debt of Advanz Pharma Corp can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Advanz Pharma Corp?

Some factors that can influence the debt of Advanz Pharma Corp include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Advanz Pharma Corp so important for investors?

The debts of Advanz Pharma Corp are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Advanz Pharma Corp take to change the debt?

To change the debt, Advanz Pharma Corp can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Advanz Pharma Corp pay?

Over the past 12 months, Advanz Pharma Corp paid a dividend of 67.5 USD . This corresponds to a dividend yield of about 395.66 %. For the coming 12 months, Advanz Pharma Corp is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanz Pharma Corp?

The current dividend yield of Advanz Pharma Corp is 395.66 %.

When does Advanz Pharma Corp pay dividends?

Advanz Pharma Corp pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Advanz Pharma Corp?

Advanz Pharma Corp paid dividends every year for the past 0 years.

What is the dividend of Advanz Pharma Corp?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanz Pharma Corp located?

Advanz Pharma Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanz Pharma Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanz Pharma Corp from 7/29/2016 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2016.

When did Advanz Pharma Corp pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Advanz Pharma Corp in the year 2023?

In the year 2023, Advanz Pharma Corp distributed 0 USD as dividends.

In which currency does Advanz Pharma Corp pay out the dividend?

The dividends of Advanz Pharma Corp are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Advanz Pharma Corp

Our stock analysis for Advanz Pharma Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanz Pharma Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.